"Centocor Royalties"
- Date:
- 1992-2006
- Reference:
- SA/KET/C/2/9/10
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
About this work
Description
Correspondence relating to Centocor quarterly royalty payments to the Kennedy Trust for Remicade; amended Centocor and Kennedy research and licensing agreement, Wyeth/Amgen licensing agreement relating to Enbrel plus methotrexate; royalty agreement between Centocor and Abbott laboratories and correspondence relating to dispute on Abbott royalties payments for Humira and background Kennedy Institute and Centocor research collaboration papers.
Publication/Creation
1992-2006
Physical description
1 file (in 4 parts)
Terms of use
This item is closed and cannot be accessed. Please see our Access Policy for more details. Closed until 1 January 2037.
Where to find it
Location Status Access Closed storesClosed Can't be requested